نتائج البحث

Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease.

• Authors : Peña-Bautista C; Alzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.; Álvarez-Sánchez L

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/blood ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid ; Biomarkers*/Biomarkers*/Biomarkers*/blood

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 13; Vol. 25 (10). Date of Electronic Publication: 2024 May 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Combination of Tramiprosate, Curcumin, and SP600125 Reduces the Neuropathological Phenotype in Familial Alzheimer Disease PSEN1 I416T Cholinergic-like Neurons.

• Authors : Gomez-Sequeda N; Neuroscience Research Group, Faculty of Medicine, Institute of Medical Research, University of Antioquia, University Research Headquarters, Calle 62#52-59, Building 1, Laboratory 411/412, Medellin 050010, Colombia.; Jimenez-Del-Rio M

Subjects: Curcumin*/Curcumin*/Curcumin*/pharmacology ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 30; Vol. 25 (9). Date of Electronic Publication: 2024 Apr 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics-Poisson-Boltzmann Surface Area Calculations.

• Authors : Chennai HY; Group of Computational and Medicinal Chemistry, LMCE Laboratory, University of Biskra, BP 145, Biskra 707000, Algeria.; Belaidi S

Subjects: Cholinesterase Inhibitors*/Cholinesterase Inhibitors*/Cholinesterase Inhibitors*/chemistry ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alkaloids*

• Source: Molecules (Basel, Switzerland) [Molecules] 2024 Mar 10; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Association of Plasma Claudin-5 with Age and Alzheimer Disease.

• Authors : Tachibana K; Graduate School of Pharmaceutical Sciences, Osaka University, Suita 565-0871, Osaka, Japan.; Hirayama R

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/blood ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/diagnosis ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 24; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease.

• Authors : Pérez-Silanes S; Department of Pharmaceutical Sciences, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain.; Martisova E

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Piperidines*; Humans

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 08; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

A Combination of Heavy Metals and Intracellular Pathway Modulators Induces Alzheimer Disease-like Pathologies in Organotypic Brain Slices.

• Authors : Korde DS; Laboratory of Psychiatry and Experimental Alzheimer's Research, Medical University of Innsbruck, 6020 Innsbruck, Austria.; Humpel C

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism; Mice ; Animals

• Source: Biomolecules [Biomolecules] 2024 Jan 30; Vol. 14 (2). Date of Electronic Publication: 2024 Jan 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Aβ1-42 Accumulation Accompanies Changed Expression of Ly6/uPAR Proteins, Dysregulation of the Cholinergic System, and Degeneration of Astrocytes in the Cerebellum of Mouse Model of Early Alzheimer Disease.

• Authors : Bychkov ML; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 119997 Moscow, Russia.; Isaev AB

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism ; Neurodegenerative Diseases*/Neurodegenerative Diseases*/Neurodegenerative Diseases*/metabolism ; Receptors, Nicotinic*/Receptors, Nicotinic*/Receptors, Nicotinic*/metabolism

• Source: International journal of molecular sciences [Int J Mol Sci] 2023 Oct 03; Vol. 24 (19). Date of Electronic Publication: 2023 Oct 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Adipocyte-Derived Small Extracellular Vesicles from Patients with Alzheimer Disease Carry miRNAs Predicted to Target the CREB Signaling Pathway in Neurons.

• Authors : Batabyal RA; Center for Genetic Medicine, Children's National Hospital, Washington, DC 20012, USA.; School of Medicine and Health Sciences, The George Washington University, Washington, DC 20037, USA.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/genetics ; Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics

• Source: International journal of molecular sciences [Int J Mol Sci] 2023 Sep 13; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 13.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Controversial Past, Splendid Present, Unpredictable Future: A Brief Review of Alzheimer Disease History.

• Authors : Bermejo-Pareja, Félix^1,2 (AUTHOR) ; del Ser, Teodoro³ (AUTHOR)

• Source: Journal of Clinical Medicine. Jan2024, Vol. 13 Issue 2, p536. 44p.

تفاصيل العنوان

Evaluation of Novel B1R/B2R Agonists Containing TRIOZAN™ Nanoparticles for Targeted Brain Delivery of Antibodies in a Mouse Model of Alzheimer Disease.

• Authors : Gagnon M; Department of Pharmacology & Physiology, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.; Savard M

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism; Animals

• Source: Molecules (Basel, Switzerland) [Molecules] 2023 Jul 04; Vol. 28 (13). Date of Electronic Publication: 2023 Jul 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium:

تفاصيل العنوان